Introduction
Background
Erysipelas is a skin infection typically caused by group A beta-hemolytic streptococci, although other streptococcal groups are occasionally causative agents. Infection involves the dermis and lymphatics and is a more superficial subcutaneous infection of the skin than cellulitis. Erysipelas is characterized by intense erythema, induration, and a sharply demarcated border, which differentiates it from other skin infections.1
Pathophysiology
The skin is the primary organ system affected.
Frequency
United States
Increasing incidence has been noted since the late 1980s.
Mortality/Morbidity
Erysipelas generally is benign; however, it can be fatal when associated with bacteremia in very young, elderly, or immunocompromised patients. The mortality rate is less than 1% in treated cases.
Sex
Slight female predominance is observed.
Age
Infection occurs at extremes of age, but erysipelas is primarily a disease of adults.
Clinical
History
- Erysipelas is a febrile illness with dermatological findings, characterized by an abrupt onset of illness with initial fever and chills followed by a painful rash occurring 1-2 days later.
- Muscle and joint pain may accompany illness.
- Nausea may be present.
- Headache and other systemic manifestations of an infectious process may occur.
- Skin discomfort is noted.
Physical
- The patient may appear healthy or toxic depending on the extent of infection.
- Fever is common.
- Dermatologic signs
- Painful, erythematous, and edematous rash
- Sharply-raised border with abrupt demarcation from healthy adjacent skin
- Condition found in lower extremities in 70-80% of patients; face, as in the image below, affected in 5-20% of patients2
- Erythema is irregular with extensions that may follow lymphatic channels (lymphangitis).
- Desquamation
- Vesicles
- Lymphadenopathy
Causes
- Group A streptococci are the most common cause.3 Less common etiologies include group G, C, and B streptococci and, rarely, staphylococci.
- A defect in skin barrier allows the infection to occur. Infection may occur after trauma, abrasions, skin ulcers, insect bites, eczema, and psoriatic lesions.
- Other predisposing factors
- Lymphatic obstruction or edema
- Saphenous vein grafting in lower extremities
- Status postradical mastectomy
- Immunocompromised patients, including patients who are diabetic or alcoholic
- Arteriovenous insufficiency
- Paretic limbs
More on Erysipelas |
Overview: Erysipelas |
| Differential Diagnoses & Workup: Erysipelas |
| Treatment & Medication: Erysipelas |
| Follow-up: Erysipelas |
| Multimedia: Erysipelas |
| References |
| Next Page » |
References
Bonnetblanc JM, Bedane C. Erysipelas: recognition and management. Am J Clin Dermatol. 2003;4(3):157-63. [Medline].
Morris AD. Cellulitis and erysipelas. Clin Evid (Online). Jan 2 2008;2008:[Medline].
Bernard P. Management of common bacterial infections of the skin. Curr Opin Infect Dis. Apr 2008;21(2):122-8. [Medline].
Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. Jan 25 1996;334(4):240-5. [Medline].
Bratton RL, Nesse RE. St. Anthony's Fire: diagnosis and management of erysipelas. Am Fam Physician. Feb 1 1995;51(2):401-4. [Medline].
Chartier C, Grosshans E. Erysipelas. Int J Dermatol. Sep 1990;29(7):459-67. [Medline].
Elston DM. Epidemiology and prevention of skin and soft tissue infections. Cutis. May 2004;73(5 Suppl):3-7. [Medline].
Jorup-Ronstrom C, Britton S. Recurrent erysipelas: predisposing factors and costs of prophylaxis. Infection. Mar-Apr 1987;15(2):105-6. [Medline].
Krasagakis K, Samonis G, Maniatakis P, Georgala S, Tosca A. Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. Dermatology. 2006;212(1):31-5. [Medline].
Lopez FA, Lartchenko S. Skin and soft tissue infections. Infect Dis Clin North Am. Dec 2006;20(4):759-72, v-vi. [Medline].
Morris A. Cellulitis and erysipelas. Clin Evid. Jun 2006;2207-11. [Medline].
Swartz MN. Erysipelas. In: Mandell GL, ed, et al. Principles and Practice of Infectious Diseases. 4th ed. Churchill Livingstone; 1995:913-14.
Torok L. Uncommon manifestations of erysipelas. Clin Dermatol. Sep-Oct 2005;23(5):515-8. [Medline].
Further Reading
Keywords
erysipelas, erysipelas causes, erysipelas treatment, erysipelas symptoms, cellulitis, group A beta-hemolytic streptococci, hemolytic streptococcus, skin infection, painful rash, erythematous rash


Overview: Erysipelas